The Home Depot Inc. (HD) Rises 2.98% After Earnings, Profit Beats Forecast and Beats Revenue
· Stocks · QuoteReporter
Post Earning Analysis
The Home Depot Inc. (HD) Rises 2.98% After Earnings, Profit Beats Forecast and Beats Revenue
The Home Depot, Inc., founded in 1978 and headquartered in Atlanta, Georgia, is a leading retailer in building materials, home improvement products, and related services. It operates across the U.S., Canada, and Mexico, offering a wide range of products from lawn and garden items to decor and building materials. The company also provides installation services and rents out tools and equipment.
The stock market is experiencing significant movements influenced by various factors including corporate earnings and economic policies. Notably, Home Depot has surpassed Q4 earnings and revenue expectations, causing its stock to rise by 2.3%. This performance is a positive signal, especially considering the tough housing market conditions. Additionally, AMD’s stock surged following a deal with Meta, highlighting strong market activities around tech stocks.
In broader market news, the implementation of new tariffs under President Trump’s administration has begun, affecting the S&P 500 and Nasdaq, though they showed signs of recovery. This policy change could potentially impact international trade dynamics and market sentiment. Meanwhile, the Dow Jones also demonstrated resilience, recovering after a significant sell-off, influenced by these geopolitical and policy shifts.
These developments are critical for investors as they navigate through potential volatility and assess the implications of corporate performances and economic policies on their investment strategies.
The current price of the asset is $389.25, marking a significant increase of 2.98% today. This price is relatively stable within its 52-week range, positioned closer to the high ($424.01) than the low ($320.39), indicating a generally bullish trend over the past year with a 21.49% increase from the 52-week low, yet still 8.2% below the 52-week high.
The moving averages suggest a positive outlook: the asset is trading above its 20-day, 50-day, and 200-day moving averages by 1.73%, 5.28%, and 4.09% respectively. This alignment above all key moving averages typically signals strong upward momentum.
The Relative Strength Index (RSI) at 57.99 is near the upper end of the neutral range, hinting at more buyers than sellers recently but not yet indicating overbought conditions. The MACD of 3.42 supports this bullish sentiment, showing a positive divergence that suggests the current upward trend might continue.
Overall, the asset exhibits robust health with a positive trend across short, medium, and long-term indicators, though it remains below its yearly and YTD highs, suggesting there might still be room for growth before encountering major resistance.
Earnings Trend Table
| Date | Estimate EPS | Reported EPS | Surprise % | |
|---|---|---|---|---|
| 0 | 2026-02-24 | 2.53 | 2.72 | 7.51 |
| 1 | 2025-05-20 | 3.60 | 3.56 | -1.00 |
| 2 | 2025-02-25 | 3.01 | 3.02 | 0.38 |
| 3 | 2024-11-12 | 3.64 | 3.67 | 0.81 |
| 4 | 2024-08-13 | 4.49 | 4.60 | 2.36 |
| 5 | 2024-05-14 | 3.60 | 3.63 | 0.85 |
| 6 | 2024-02-20 | 2.77 | 2.82 | 1.95 |
| 7 | 2023-11-14 | 3.76 | 3.81 | 1.28 |
The EPS trends over the observed quarters demonstrate a generally positive performance relative to estimates, with most quarters showing a surpassing of analyst expectations. Notably, the highest EPS surprise occurred in Q1 2026 with a 7.51% increase over the estimate, where the actual EPS was reported at 2.72 against an estimate of 2.53. This indicates a strong start to the year, possibly driven by effective operational efficiencies or revenue growth exceeding expectations.
Conversely, Q2 2025 shows a slight underperformance with a -1.00% surprise, where the reported EPS of 3.56 fell short of the estimate of 3.60. This deviation suggests a temporary setback or unmet projections during that period. However, this appears to be an anomaly as subsequent and prior quarters consistently outperformed expectations, such as Q3 2024 where the EPS of 4.60 exceeded the estimate by 2.36%.
Seasonal variations in EPS can also be observed, with higher estimates and reported figures generally in the mid-year quarters, indicative of cyclical business impacts. Overall, the company’s ability to frequently meet or exceed analyst projections suggests robust financial health and effective management execution.
Dividend Payments Table
| Date | Dividend |
|---|---|
| 2025-12-04 | 2.3 |
| 2025-09-04 | 2.3 |
| 2025-06-05 | 2.3 |
| 2025-03-13 | 2.3 |
| 2024-11-27 | 2.25 |
| 2024-08-29 | 2.25 |
| 2024-05-30 | 2.25 |
| 2024-03-06 | 2.25 |
The dividend data spanning from March 2024 to December 2025 reveals a discernible trend in dividend adjustments. Throughout 2024, the dividend amount was consistently set at 2.25. This stability suggests a period of financial steadiness or a strategic decision by the company to maintain a predictable return to shareholders during that year.
However, a notable change occurred at the onset of 2025, where the dividend was increased to 2.3 and maintained at this slightly higher rate across all four quarters of the year. This incremental increase, although modest, indicates a possible improvement in the company’s financial health or a confidence in sustained earnings, allowing for a higher distribution to shareholders. The consistency observed post-adjustment throughout 2025 also underscores a continued commitment to shareholder value, suggesting a positive outlook by the company’s management regarding the future financial performance. This trend of stable yet progressive dividend payments could be appealing to investors seeking reliable and potentially growing income streams.
The four most recent rating changes for the stock in question exhibit a mix of reassessment and strategic realignment by notable financial analysis firms.
-
Telsey Advisory Group – December 10, 2025: Telsey Advisory Group reiterated its ‘Outperform’ rating but adjusted the target price from $430 to $410. This adjustment suggests a recalibration of expectations, possibly due to recent company performances or market conditions affecting the perceived value, while still maintaining a positive outlook on the stock.
-
Telsey Advisory Group – November 19, 2025: Shortly before the December adjustment, Telsey Advisory Group had already lowered its target price from $455 to $430 while maintaining the ‘Outperform’ rating. This sequential lowering of the target price within a month indicates a trend of moderated optimism, potentially due to evolving market dynamics or less favorable than expected company financials or operational results.
-
Stifel – November 14, 2025: Stifel downgraded the stock from ‘Buy’ to ‘Hold,’ a significant shift that suggests a change in the firm’s long-term confidence in the stock’s performance potential. Although no specific target price was provided, this downgrade could reflect concerns over challenges that might impede the company’s growth or profitability.
-
Wolfe Research – September 18, 2025: Wolfe Research resumed coverage with an ‘Outperform’ rating and set a target price of $497. This optimistic stance and high target price indicate a strong bullish outlook on the stock, suggesting confidence in the company’s future growth trajectory and market position at that time.
Overall, these rating changes highlight a mixed sentiment among analysts, with Wolfe Research showing high confidence in September, while subsequent assessments by Telsey Advisory Group and Stifel indicate increasing caution and recalibrated expectations towards the end of 2025.
As of the latest data, the current price of the stock stands at $389.25. This price is notably below the average target price provided by various analysts. The most recent ratings from Telsey Advisory Group on December 10, 2025, suggest a target price of $410, downgraded from a previous target of $430. Earlier, on November 19, 2025, the same group adjusted their target from $455 to $430. Additionally, Wolfe Research, resuming coverage on September 18, 2025, set an even higher target price of $497. However, Stifel downgraded the stock from “Buy” to “Hold” on November 14, 2025, without specifying a new target price.
The adjustments in target prices and the downgrade indicate a mixed but generally optimistic outlook from analysts, with expectations of growth despite recent downgrades. The substantial gap between the current stock price and the analysts’ target prices suggests potential undervaluation, assuming the analysts’ forecasts hold true.
Disclaimer: The information provided here is for educational and informational purposes only and should not be interpreted as financial advice, investment recommendations, or trading guidance. Markets involve risk, and past performance is not indicative of future results. You should always conduct your own research and consult with a qualified financial advisor before making any investment decisions. By acting, you accept full responsibility for your choices.